卵巢癌
小RNA
下调和上调
缺氧(环境)
癌症研究
免疫印迹
核糖核酸
生物
表型
癌症
肿瘤进展
医学
信使核糖核酸
卵巢肿瘤
小干扰RNA
化学
生物信息学
基因表达
卵巢
污渍
基因表达调控
肿瘤科
免疫学
分子生物学
RNA提取
内科学
基因
作者
Wenjie Zeng,Hubin Xu,Huafeng Shou,Haimin Jiang,Mengyu Zhang,Xiaoyan Chen,Weiguo Lü
标识
DOI:10.1631/jzus.b2500083
摘要
This study aimed to examine hypoxia-induced phenotypic alterations in ovarian cancer and to elucidate the molecular mechanisms mediated by long non-coding RNAs (lncRNAs). Transwell assay was used to assess migration and invasion, and methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay was used to assess proliferation. Western blot analysis was conducted to evaluate the expression of factors associated with epithelial–mesenchymal transition (EMT). RNA sequencing was carried out to identify potential targets, and dual-luciferase and biotin-labeled microRNA (miRNA) pull-down assays were performed to identify interactions between these targets. Gain- and loss-of-function experiments were conducted to validate their effects. Hypoxia promoted the migration, invasion, and EMT of HO8910 and A2780 cells. Under hypoxic conditions, the expression of lncRNA-aspartyl-transfer RNA synthetase antisense RNA 1 (lnc- DARS-AS1 ) was significantly increased, and this upregulation exerted a proliferative effect on ovarian cancer cells. Furthermore, lnc- DARS-AS1 promoted solute carrier family 2 member 12 (SLC2A12) expression, accelerating ovarian cancer progression. Luciferase, biotin-labeled miRNA pull-down, and cellular function assays confirmed that lnc- DARS-AS1 binds to miR-378a-5p to enhance SLC2A12 levels. The expression levels of SLC2A12 were determined in samples from patients with ovarian cancer, and they showed a positive correlation with cancer progression. This research established that the lnc- DARS-AS1 /miR-378a-5p/SLC2A12 axis is involved in ovarian cancer progression under hypoxic conditions, providing new perspectives on the treatment and management of ovarian cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI